Prime Medicine to Participate in Upcoming Investor Conferences

Prime Medicine (PRME) will participate in three investor and healthcare conferences in September 2026, featuring 1x1 investor meetings and fireside chats in Boston and New York.

Rhea-AI Summary

Prime Medicine (PRME) will participate in three investor and healthcare conferences in September 2026, featuring 1x1 investor meetings and fireside chats in Boston and New York.

Management will host 1x1 meetings at the Wells Fargo 21st Annual Healthcare Conference on Thursday, September 10, 2026, in Boston, MA. The company will hold a fireside chat at the H.C. Wainwright 28th Annual Global Investment Conference on Tuesday, September 15, 2026, at 9:30 a.m. ET, and another fireside chat at the Morgan Stanley Global Healthcare Conference on Wednesday, September 16, 2026, at 10:00 a.m. ET, both in New York, NY.

Live audio webcasts of the fireside chats will be available in the News & Events section of Prime Medicine’s website under “Events & Presentations,” with replays accessible for 90 days after each event.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CAMBRIDGE, Mass., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that company management will participate in three upcoming conferences:

• Wells Fargo 21st Annual Healthcare Conference: Company management will host 1x1 meetings on Thursday, September 10, 2026, in Boston, MA.
• H.C. Wainwright 28th Annual Global Investment Conference: Fireside chat on Tuesday, September 15, 2026, at 9:30 a.m. ET in New York, NY.
• Morgan Stanley Global Healthcare Conference: Fireside chat on Wednesday, September 16, 2026, at 10:00 a.m. ET in New York, NY.
  
  

Live audio webcasts of the fireside chats will be available under “Events & Presentations” in the News & Events section of the Company’s website at www.primemedicine.com. Replays of each webcast will be available on the Prime Medicine website for 90 days following the event.

About Prime Medicine

Prime Medicine is a leading biotechnology company dedicated to creating and delivering the next generation of gene editing therapies to patients. The Company is deploying its proprietary Prime Editing platform, a versatile, precise and efficient gene editing technology, to develop a new class of differentiated one-time curative genetic therapies. Designed to make only the right edit at the right position within a gene while minimizing unwanted DNA modifications, Prime Editors have the potential to repair almost all types of genetic mutations and work in many different tissues, organs and cell types. Taken together, Prime Editing’s versatile gene editing capabilities could unlock opportunities across thousands of potential indications.

Prime Medicine is currently progressing a diversified portfolio of investigational therapeutic programs organized around our core areas of focus: liver, lung, and immunology and oncology. Across each core area, Prime Medicine is focused initially on a set of high value programs, each targeting a disease with well-understood biology and a clearly defined clinical development and regulatory path, and each expected to provide the foundation for expansion into additional opportunities. Over time, the Company intends to maximize Prime Editing’s broad and versatile therapeutic potential, as well as the modularity of the Prime Editing platform, to rapidly and efficiently expand beyond the diseases in its current pipeline, potentially including additional genetic diseases, immunological diseases, cancers, infectious diseases, and targeting genetic risk factors in common diseases, which collectively impact millions of people. For more information, please visit www.primemedicine.com.

© 2026 Prime Medicine, Inc. All rights reserved. PRIME MEDICINE, the Prime Medicine logos, and PASSIGE are trademarks of Prime Medicine, Inc. All other trademarks referred to herein are the property of their respective owners.

Investor and Media Contacts

Gregory Dearborn
Prime Medicine
857-209-0696
gdearborn@primemedicine.com 

Hannah Deresiewicz
Precision AQ
212-362-1200
hannah.deresiewicz@precisionaq.com

FAQ

When will Prime Medicine (PRME) participate in the Wells Fargo 21st Annual Healthcare Conference?

Prime Medicine management will host 1x1 meetings at the Wells Fargo 21st Annual Healthcare Conference on Thursday, September 10, 2026, in Boston, MA. The company describes this as an opportunity for direct investor engagement.

What are the date and time of Prime Medicine’s H.C. Wainwright fireside chat for PRME investors?

Prime Medicine will hold a fireside chat at the H.C. Wainwright 28th Annual Global Investment Conference on Tuesday, September 15, 2026, at 9:30 a.m. ET in New York, NY. A live audio webcast will be available on its website.

When is Prime Medicine’s Morgan Stanley Global Healthcare Conference fireside chat for PRME?

The fireside chat at the Morgan Stanley Global Healthcare Conference is scheduled for Wednesday, September 16, 2026, at 10:00 a.m. ET in New York, NY. Investors can access a live audio webcast via the company’s News & Events page.

How can investors access the Prime Medicine (PRME) conference webcasts and replays?

Live audio webcasts of Prime Medicine’s fireside chats will be available under “Events & Presentations” in the News & Events section of www.primemedicine.com. Replays of each webcast will remain accessible on the website for 90 days after the event.

Which investor and healthcare conferences will Prime Medicine (PRME) attend in September 2026?

Prime Medicine will join three events: the Wells Fargo 21st Annual Healthcare Conference in Boston on September 10, 2026, and the H.C. Wainwright 28th Annual Global Investment Conference and Morgan Stanley Global Healthcare Conference in New York on September 15 and 16, 2026.